Literature DB >> 33551984

Cognitive Processes Underlying Verbal Fluency in Multiple Sclerosis.

Alfonso Delgado-Álvarez1, Jordi A Matias-Guiu1, Cristina Delgado-Alonso1, Laura Hernández-Lorenzo1, Ana Cortés-Martínez1, Lucía Vidorreta1, Paloma Montero-Escribano1, Vanesa Pytel1, Jorge Matias-Guiu1.   

Abstract

Background: Verbal fluency (VF) has been associated with several cognitive functions, but the cognitive processes underlying verbal fluency deficits in Multiple Sclerosis (MS) are controversial. Further knowledge about VF could be useful in clinical practice, because these tasks are brief, applicable, and reliable in MS patients. In this study, we aimed to evaluate the cognitive processes related to VF and to develop machine-learning algorithms to predict those patients with cognitive deficits using only VF-derived scores.
Methods: Two hundred participants with MS were enrolled and examined using a comprehensive neuropsychological battery, including semantic and phonemic fluencies. Automatic linear modeling was used to identify the neuropsychological test predictors of VF scores. Furthermore, machine-learning algorithms (support vector machines, random forest) were developed to predict those patients with cognitive deficits using only VF-derived scores.
Results: Neuropsychological tests associated with attention-executive functioning, memory, and language were the main predictors of the different fluency scores. However, the importance of memory was greater in semantic fluency and clustering scores, and executive functioning in phonemic fluency and switching. Machine learning algorithms predicted general cognitive impairment and executive dysfunction, with F1-scores over 67-71%. Conclusions: VF was influenced by many other cognitive processes, mainly including attention-executive functioning, episodic memory, and language. Semantic fluency and clustering were more explained by memory function, while phonemic fluency and switching were more related to executive functioning. Our study supports that the multiple cognitive components underlying VF tasks in MS could serve for screening purposes and the detection of executive dysfunction.
Copyright © 2021 Delgado-Álvarez, Matias-Guiu, Delgado-Alonso, Hernández-Lorenzo, Cortés-Martínez, Vidorreta, Montero-Escribano, Pytel and Matias-Guiu.

Entities:  

Keywords:  cognitive; fluency; machine learning; multiple sclerosis; neuropsychology; processing speed

Year:  2021        PMID: 33551984      PMCID: PMC7859643          DOI: 10.3389/fneur.2020.629183

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  25 in total

1.  The differing roles of the frontal cortex in fluency tests.

Authors:  Gail Robinson; Tim Shallice; Marco Bozzali; Lisa Cipolotti
Journal:  Brain       Date:  2012-06-04       Impact factor: 13.501

2.  Spanish Multicenter Normative Studies (NEURONORMA Project): methods and sample characteristics.

Authors:  Jordi Peña-Casanova; Rafael Blesa; Miquel Aguilar; Nina Gramunt-Fombuena; Beatriz Gómez-Ansón; Rafael Oliva; José Luis Molinuevo; Alfredo Robles; María Sagrario Barquero; Carmen Antúnez; Carlos Martínez-Parra; Anna Frank-García; Manuel Fernández; Verónica Alfonso; Josep M Sol
Journal:  Arch Clin Neuropsychol       Date:  2009-06-23       Impact factor: 2.813

3.  Verbal fluency as a rapid screening test for cognitive impairment in progressive multiple sclerosis.

Authors:  Peter Connick; Madhan Kolappan; Thomas H Bak; Siddharthan Chandran
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-03-02       Impact factor: 10.154

Review 4.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Authors:  Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen
Journal:  Lancet Neurol       Date:  2017-12-21       Impact factor: 44.182

5.  What (more) can verbal fluency tell us about multiple sclerosis?

Authors:  Elise Barois; Yoshimasa Sagawa; Suveyla Yilmaz; Eloi Magnin; Pierre Decavel
Journal:  Ann Phys Rehabil Med       Date:  2020-10-17

6.  Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests.

Authors:  Francesco Saccà; Teresa Costabile; Filomena Abate; Agnese Liguori; Francesca Paciello; Chiara Pane; Anna De Rosa; Fiore Manganelli; Giuseppe De Michele; Alessandro Filla
Journal:  J Neuropsychol       Date:  2017-05-06       Impact factor: 2.864

7.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

8.  Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation.

Authors:  Jordi A Matias-Guiu; Ana Cortés-Martínez; María Valles-Salgado; Celia Oreja-Guevara; Vanesa Pytel; Paloma Montero; Teresa Moreno-Ramos; Jorge Matias-Guiu
Journal:  Front Neurol       Date:  2017-11-28       Impact factor: 4.003

9.  Identification of Cortical and Subcortical Correlates of Cognitive Performance in Multiple Sclerosis Using Voxel-Based Morphometry.

Authors:  Jordi A Matías-Guiu; Ana Cortés-Martínez; Paloma Montero; Vanesa Pytel; Teresa Moreno-Ramos; Manuela Jorquera; Miguel Yus; Juan Arrazola; Jorge Matías-Guiu
Journal:  Front Neurol       Date:  2018-10-29       Impact factor: 4.003

10.  Association Between White Matter Microstructure and Verbal Fluency in Patients With Multiple Sclerosis.

Authors:  Tal Blecher; Shmuel Miron; Galit Grimberg Schneider; Anat Achiron; Michal Ben-Shachar
Journal:  Front Psychol       Date:  2019-07-18
View more
  3 in total

1.  Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates.

Authors:  Arwa Rekik; Mona Aissi; Islem Rekik; Mariem Mhiri; Mahbouba Ayed Frih
Journal:  Brain Behav       Date:  2022-04-10       Impact factor: 3.405

2.  Subjective cognitive decline is associated with a higher risk of objective cognitive decline: A cross-sectional and longitudinal study.

Authors:  Wei Li; Ling Yue; Shifu Xiao
Journal:  Front Psychiatry       Date:  2022-09-29       Impact factor: 5.435

3.  Regression-Based Normative Data for Independent and Cognitively Active Spanish Older Adults: Verbal Fluency Tests and Boston Naming Test.

Authors:  Clara Iñesta; Javier Oltra-Cucarella; Esther Sitges-Maciá
Journal:  Int J Environ Res Public Health       Date:  2022-09-11       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.